The effect of olanzapine on IGF-1/IGF-1R and volumes in the prefrontal cortex and hippocampus in a model of bipolar mania
PSYCHIATRIA DANUBINA · 2025
DOI: 10.24869/psyd.2025.310 ↗Kurz gefasst
Fachartikel in der Zeitschrift PSYCHIATRIA DANUBINA, 2025. Verfasst von Eser Çakmak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry Department, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey. Hauptthemen laut MEDLINE: Prefrontal Cortex, Hippocampus, Receptor, IGF Type 1, Insulin-Like Growth Factor I. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The aim of the study is to determine the changes in insulin-like growth factor 1 (IGF-1) and its receptor (IGF-1R) in the emergence of bipolar disorder and its treatment with olanzapine. SUBJECTS AND METHODS: Of all 48 adult male albino wistar rats, the control group (n=12) saline, ketamine group (n=12) ketamine (25mg/kg), olanzapine group (n=12) olanzapine (2mg/kg), ketamine+olanzapine group (n=12) ketamine (25 mg/kg) was administered once a day/14 days. Olanzapine (2mg/kg) was administered once a day to the ketamine+olanzapine group between 8 and 14 days. Volume, IGF-1, and IGF-1R gene expression and protein levels were measured in the prefrontal cortex and hippocampus. RESULTS: In the prefrontal cortex, there was a decrease in volume, IGF-1R gene expression, and protein levels in the ketamine group, an increase in IGF-1 gene expression and protein levels in the olanzapine group; an increase in IGF-1R gene expression, IGF-1, and IGF-1R protein levels in the ketamine+olanzapine group. In hippocampus, there was a decrease in volume, IGF-1 gene expression and protein levels in ketamine group, a decrease in volume and IGF-1 protein levels, increase in IGF-1R gene expression and protein levels in olanzapine group; a decrease in volume, IGF-1 protein levels and IGF-1R gene expression and protein levels in ketamine+olanzapine group. CONCLUSIONS: One of the underlying causes of bipolar disorder may be changes in the IGF-1 and IGF-1R regions in the prefrontal cortex and hippocampus. Olanzapine has a neuroprotective effect by increasing IGF-1 and IGF-1R levels in the prefrontal cortex, and a neurodegenerative effect by decreasing IGF-1 and IGF-1R levels in the hippocampus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Biochemistry Department, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
- Histology and Embryology Department, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Zitieren
APA
Çakmak, E., Tunçel, Ö. K., & Önger, M. E. (2025). The effect of olanzapine on IGF-1/IGF-1R and volumes in the prefrontal cortex and hippocampus in a model of bipolar mania. PSYCHIATRIA DANUBINA. https://doi.org/10.24869/psyd.2025.310
Vancouver
Çakmak E, Tunçel ÖK, Önger ME. The effect of olanzapine on IGF-1/IGF-1R and volumes in the prefrontal cortex and hippocampus in a model of bipolar mania. PSYCHIATRIA DANUBINA. 2025. doi:10.24869/psyd.2025.310
BibTeX
@article{akmak2025,
author = {Çakmak, Eser and Tunçel, Özgür Korhan and Önger, Mehmet Emin},
title = {The effect of olanzapine on IGF-1/IGF-1R and volumes in the prefrontal cortex and hippocampus in a model of bipolar mania},
journal = {PSYCHIATRIA DANUBINA},
year = {2025},
doi = {10.24869/psyd.2025.310}
}
EUVIMED